326 POSTER Dose-finding study of pegylated liposomal doxorubicin (PLD) and the mTOR inhibitor RAD001 (R) in patients (pts) with advanced solid tumors
C. Sessa, A. Perotti, A. Delmonte, G. Del Conte, E. Gallerani, A. Fasolo, F. Zanaboni, A. Locatelli, E. Dall'O', L. GianniVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72260-2
File:
PDF, 57 KB
english, 2008